Cargando…
Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228906/ https://www.ncbi.nlm.nih.gov/pubmed/34167475 http://dx.doi.org/10.1186/s12879-021-06132-5 |
| _version_ | 1783712852244168704 |
|---|---|
| author | Li, Yao Huang, Xiaojie Chen, Hui Qin, Yuanyuan Hou, Jianhua Li, Aixin Wu, Hao Yan, Xiaofeng Chen, Yaokai |
| author_facet | Li, Yao Huang, Xiaojie Chen, Hui Qin, Yuanyuan Hou, Jianhua Li, Aixin Wu, Hao Yan, Xiaofeng Chen, Yaokai |
| author_sort | Li, Yao |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8228906 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-82289062021-06-28 Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis Li, Yao Huang, Xiaojie Chen, Hui Qin, Yuanyuan Hou, Jianhua Li, Aixin Wu, Hao Yan, Xiaofeng Chen, Yaokai BMC Infect Dis Correction BioMed Central 2021-06-24 /pmc/articles/PMC8228906/ /pubmed/34167475 http://dx.doi.org/10.1186/s12879-021-06132-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Li, Yao Huang, Xiaojie Chen, Hui Qin, Yuanyuan Hou, Jianhua Li, Aixin Wu, Hao Yan, Xiaofeng Chen, Yaokai Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis |
| title | Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis |
| title_full | Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis |
| title_fullStr | Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis |
| title_full_unstemmed | Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis |
| title_short | Correction to: The prevalence of cryptococcal antigen (CrAg) and benefits of pre-emptive antifungal treatment among HIV-infected persons with CD4+ T-cell counts < 200 cells/μL: evidence based on a meta-analysis |
| title_sort | correction to: the prevalence of cryptococcal antigen (crag) and benefits of pre-emptive antifungal treatment among hiv-infected persons with cd4+ t-cell counts < 200 cells/μl: evidence based on a meta-analysis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228906/ https://www.ncbi.nlm.nih.gov/pubmed/34167475 http://dx.doi.org/10.1186/s12879-021-06132-5 |
| work_keys_str_mv | AT liyao correctiontotheprevalenceofcryptococcalantigencragandbenefitsofpreemptiveantifungaltreatmentamonghivinfectedpersonswithcd4tcellcounts200cellsmlevidencebasedonametaanalysis AT huangxiaojie correctiontotheprevalenceofcryptococcalantigencragandbenefitsofpreemptiveantifungaltreatmentamonghivinfectedpersonswithcd4tcellcounts200cellsmlevidencebasedonametaanalysis AT chenhui correctiontotheprevalenceofcryptococcalantigencragandbenefitsofpreemptiveantifungaltreatmentamonghivinfectedpersonswithcd4tcellcounts200cellsmlevidencebasedonametaanalysis AT qinyuanyuan correctiontotheprevalenceofcryptococcalantigencragandbenefitsofpreemptiveantifungaltreatmentamonghivinfectedpersonswithcd4tcellcounts200cellsmlevidencebasedonametaanalysis AT houjianhua correctiontotheprevalenceofcryptococcalantigencragandbenefitsofpreemptiveantifungaltreatmentamonghivinfectedpersonswithcd4tcellcounts200cellsmlevidencebasedonametaanalysis AT liaixin correctiontotheprevalenceofcryptococcalantigencragandbenefitsofpreemptiveantifungaltreatmentamonghivinfectedpersonswithcd4tcellcounts200cellsmlevidencebasedonametaanalysis AT wuhao correctiontotheprevalenceofcryptococcalantigencragandbenefitsofpreemptiveantifungaltreatmentamonghivinfectedpersonswithcd4tcellcounts200cellsmlevidencebasedonametaanalysis AT yanxiaofeng correctiontotheprevalenceofcryptococcalantigencragandbenefitsofpreemptiveantifungaltreatmentamonghivinfectedpersonswithcd4tcellcounts200cellsmlevidencebasedonametaanalysis AT chenyaokai correctiontotheprevalenceofcryptococcalantigencragandbenefitsofpreemptiveantifungaltreatmentamonghivinfectedpersonswithcd4tcellcounts200cellsmlevidencebasedonametaanalysis |